1. Home
  2. XBIT vs OPAL Comparison

XBIT vs OPAL Comparison

Compare XBIT & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.88

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

N/A

Current Price

$1.44

Market Cap

58.2M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
OPAL
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
58.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
XBIT
OPAL
Price
$1.88
$1.44
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $3.13
AVG Volume (30 Days)
92.8K
★ 148.0K
Earning Date
11-20-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 650.00
EPS
N/A
★ N/A
Revenue
N/A
★ $348,975,000.00
Revenue This Year
N/A
$3.57
Revenue Next Year
$30.47
$13.13
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.34
52 Week Low
$1.80
$1.42
52 Week High
$3.44
$2.87

Technical Indicators

Market Signals
Indicator
XBIT
OPAL
Relative Strength Index (RSI) 39.12 36.09
Support Level $1.80 N/A
Resistance Level $2.42 $1.65
Average True Range (ATR) 0.12 0.10
MACD -0.00 -0.00
Stochastic Oscillator 27.27 25.86

Price Performance

Historical Comparison
XBIT
OPAL

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated leader in the capture and conversion of biogas into low-carbon-intensity renewable natural gas and Renewable Power. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-decarbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas. The Company has three operating segments: RNG Fuel, Fuel Station Services, and Renewable Power.

Share on Social Networks: